Wael Y. Mansour

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Estrogen /progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells.

Estrogen /progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 11, 2026

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

Journal: British journal of cancer

Published: July 23, 2025

Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.

Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.

Journal: Molecular cancer therapeutics

Published: May 29, 2025

Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitization.

Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitization.

Journal: The Journal of clinical investigation

Published: April 28, 2025

Retinoic acid-induced 2 deficiency impairs genomic stability in breast cancer.

Retinoic acid-induced 2 deficiency impairs genomic stability in breast cancer.

Journal: Breast cancer research : BCR

Published: January 16, 2025

6-[(1,4-Naphthoquinone-2-yl)methyl]thio-Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer.

6-[(1,4-Naphthoquinone-2-yl)methyl]thio-Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer.

Journal: Molecular cancer therapeutics

Published: October 23, 2024

The histone acetyltransferase CBP participates in regulating the DNA damage response through ATM after double-strand breaks.

The histone acetyltransferase CBP participates in regulating the DNA damage response through ATM after double-strand breaks.

Journal: Genome biology

Published: April 22, 2024

Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins.

Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins.

Journal: Scientific reports

Published: January 28, 2024

Comparative study between single modality radiotherapy and concurrent chemoradiation for selected patients with early-stage laryngeal cancer.

Comparative study between single modality radiotherapy and concurrent chemoradiation for selected patients with early-stage laryngeal cancer.

Journal: American journal of cancer research

Published: June 30, 2023

Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.

Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.

Journal: Virchows Archiv : an international journal of pathology

Published: December 14, 2022

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer.

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer.

Journal: International journal of molecular sciences

Published: October 16, 2022

Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.

Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.

Journal: Molecular oncology

Published: August 10, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026